Search results
People also ask
Who is Matthew Clarke?
Who is Dr. Matthew Clark?
Who is histopathology trainee Matthew Clarke?
Where is Dr. Matthew Clarke's office located?
How did Matthew become a surgeon?
About. Dr Matthew Clarke qualified from the University of Nottingham in 2009, before training as a surgeon in London. He spent four years as clinician in charge of a busy A+E department in Sydney, Australia, before returning to the UK in 2019 to complete his general practice training. Now practising as a GP, Dr Clarke has a particular interest ...
Histopathology trainee Dr Matthew Clarke took a while to settle on pathology as a career. However, after training initially as a surgeon, he fell in love with histopathology and hasn't looked back.
I am an NIHR Academic Clinical Lecturer and diagnostic neuropathology trainee based at the National Hospital for Neurology & Neurosurgery (UCLH, London, UK) / Institute of Cancer...
- 500+
- 594
- University of London / ICR
Dr Matthew Clarke. Matthew is a neuropathology trainee (ST3) working at the National Hospital for Neurology and Neurosurgery (London) who is finishing a PhD in the molecular pathology of infant gliomas at the Institute of Cancer Research. He aims to specialise in paediatric neuropathology and molecular pathology.
- The Unusual Origins of St. Jude
- Funding
- The Pathology Department
- Integrated Research
- Global Engagement
- Wellbeing and Diversity
- My Reflections
St. Jude Children’s Research Hospital was founded in 1962 by the entertainer Danny Thomas. He had been struggling for work in this industry which led him to say a prayer to the patron saint of lost causes, St Jude Thaddeus: “Show me my way in life, and I will build you a shrine.” Shortly after this, Danny’s fortunes turned around and he enjoyed a v...
Much like the UK, healthcare in the US has many challenges in terms of provision, access, and availability. Affordability is also a particular issue in the US, with many people unable to afford health insurance, who can then face huge bills for the cost of their care. An impressive and admirable aspect of St. Jude is that the patients and their fam...
As a trainee neuropathologist and pathology enthusiast, I was eager to explore the pathology department at St. Jude. It was a very impressive department; the team of consultants were all involved in research at the hospital to varying degrees. The extent of molecular investigations was also very impressive, with the provision of a laboratory that w...
Research is integrated into the very fabric of the hospital institution. The teams are always looking for opportunities to use the data to discover new things about disease and treatment. This begins at the time of biopsy; I spoke with one of the neuropathologists who told me that in theatre, material from a brain tumour resection can be provisione...
St. Jude is also keen to ensure equality of access to treatments and good practice for patients and clinicians around the world. They run a global outreach programme, helping to provision the implementation of molecular testing for lower-middle income countries and other centres both in the US and around the world. This policy of shared learning is...
St. Jude show that they value the wellbeing of all who set foot in the hospital, and it is clear to see from the interactions with staff. Everyone was so welcoming and supportive. As you walk into the Danny Thomas Research Tower and look up, you can see many different flags representing the diversity of international staff that are employed there. ...
The time I spent at St. Jude was very inspiring. Not only did I learn a huge amount of neuropathology from some of the experts in the field, but I got to see further examples of the significant difference research can make to the outcomes of patients. Much like the relationship between the ICR and The Royal Marsden, research is integrated into pati...
Matthew is an NIHR Academic Clinical Lecturer and diagnostic neuropathology trainee based at the National Hospital for Neurology & Neurosurgery (UCLH, London, UK) / Institute of Cancer Research who has completed a PhD in the molecular pathology of infant gliomas at the ICR.
Jan 20, 2018 · Dr Matthew Clarke BSc (Hons), MBChB (Hons), MRCS, PhD, RCPathME, FRCPath. Matthew is an NIHR Clinical Lecturer in diagnostic neuropathology based at UCLH, London/Institute of Cancer Research (ICR). He completed a PhD in the molecular pathology of infant gliomas at the ICR.
